(1) Department of Clinical Medicine, Hospital of Livorno, Viale Alfieri 36, 57124 Livorno, Italy
* Corresponding author Email: firstname.lastname@example.org
Since the introduction of low-molecular-weight heparins for safely treating deep vein thrombosis, outpatient treatment of this condition became a standard practice worldwide. Certain groups of patients were not represented in clinical trials of home treatment; however, they still need to be admitted. In deciding which patient to admit, physicians should take into account both comorbid clinical conditions and social, geographic and logistic constraints. Extension of venous thromboembolism (i.e., the presence of symptomatic pulmonary embolism, iliofemoral or caval thrombosis) and the risk of bleeding should also be included in the decision pathway. The aim of this critical review is to see if deep vein thrombosis can be treated at home or at hospital.
Deep vein thrombosis can be treated outside a hospital setting safely, but this varies between individuals. Some people need to be admitted into a hospital as there is a high risk of bleeding or relevant comorbidities.
It is advisable to implement clinical pathways to support the decision of safely assigning patients to outpatient management.